HIV-I TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms
- PMID: 10620360
- DOI: 10.1006/abbi.1999.1583
HIV-I TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms
Abstract
Replication of the human immunodeficiency virus type 1 (HIV-1) is inhibited by interferons (IFNs), in part through activity of the IFN-inducible protein kinase PKR. To escape this antiviral effect, HIV-1 has developed strategies for blocking PKR function. We have previously shown that the HIV-1 Tat protein can associate with PKR in vitro and in vivo and inhibit PKR activity. Here we present evidence that Tat can inhibit PKR activity by both RNA-dependent and RNA-independent mechanisms. Tat inhibited PKR activation by the non-RNA activator heparin, and also suppressed PKR basal level autophosphorylation in the absence of RNA. However, when Tat and dsRNA were preincubated, the amount of Tat required to inhibit PKR activation by dsRNA depended on the dsRNA concentration. In addition to its function in vitro, Tat can also reverse translation inhibition mediated by PKR in COS cells. The Tat amino acid sequence required for interaction with PKR was mapped to residues 40-58, overlapping the hydrophobic core and basic region of HIV-1 Tat. Alignment of amino acid sequences of Tat and eIF-2alpha indicates similarity between the Tat-PKR binding region and the residues around the eIF-2alpha phosphorylation site, suggesting that Tat and eIF-2alpha may bind to the same site on PKR.
Copyright 2000 Academic Press.
Similar articles
-
Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA.Virology. 2006 May 25;349(1):13-21. doi: 10.1016/j.virol.2006.01.005. Epub 2006 Feb 8. Virology. 2006. PMID: 16466763
-
HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR.Virology. 1995 Nov 10;213(2):413-24. doi: 10.1006/viro.1995.0014. Virology. 1995. PMID: 7491766
-
RNA binding and modulation of PKR activity.Methods. 1998 Jul;15(3):189-98. doi: 10.1006/meth.1998.0623. Methods. 1998. PMID: 9735304
-
Multiple levels of PKR inhibition during HIV-1 replication.Rev Med Virol. 2011 Jan;21(1):42-53. doi: 10.1002/rmv.674. Epub 2010 Dec 7. Rev Med Virol. 2011. PMID: 21294215 Review.
-
Regulation of the interferon-inducible eIF-2 alpha protein kinase by small RNAs.Biochimie. 1994;76(8):770-8. doi: 10.1016/0300-9084(94)90081-7. Biochimie. 1994. PMID: 7534482 Review.
Cited by
-
Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA.Gene Ther. 2006 Oct;13(19):1403-13. doi: 10.1038/sj.gt.3302786. Epub 2006 May 18. Gene Ther. 2006. PMID: 16708080 Free PMC article.
-
Co-expression of miRNA targeting the expression of PERK, but not PKR, enhances cellular immunity from an HIV-1 Env DNA vaccine.PLoS One. 2011 Mar 25;6(3):e18225. doi: 10.1371/journal.pone.0018225. PLoS One. 2011. PMID: 21464971 Free PMC article.
-
Activation of GCN2 upon HIV-1 infection and inhibition of translation.Cell Mol Life Sci. 2013 Jul;70(13):2411-21. doi: 10.1007/s00018-013-1272-x. Epub 2013 Feb 17. Cell Mol Life Sci. 2013. PMID: 23417324 Free PMC article.
-
The PKR activator, PACT, becomes a PKR inhibitor during HIV-1 replication.Retrovirology. 2013 Sep 11;10:96. doi: 10.1186/1742-4690-10-96. Retrovirology. 2013. PMID: 24020926 Free PMC article.
-
A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cells.J Virol. 2013 Jun;87(12):6678-92. doi: 10.1128/JVI.00338-13. Epub 2013 Apr 3. J Virol. 2013. PMID: 23552412 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases